Family Med Medical News about seasonal influenza A (H1N1); H1N1 vaccine; antiviral

Become a Member Today!
Register

Most Viewed Abstracts

1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

2. Omega-3 fatty acids for bipolar disorder

3. Is folic acid good for everyone

4. ACS Releases Guidelines for HPV Vaccination

5. Vitamin D - A review Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

CDCs Advisory Committee Gives Thumbs-up to New Antiviral Recs. Agency Gearing Up for Possible H1N1 Vaccine Distribution
American Family Physician, 07/17/09

Mitchell D – Members of the CDC's Advisory Committee on Immunization Practices, or ACIP, approved new antiviral treatment recommendations during the committee's June 24–26 meeting in Atlanta. The recommendations call for use of:

zanamivir or a combination of oseltamivir and rimantadine (or amantadine if rimantadine is not available) for treatment of seasonal influenza A (H1N1) virus infection; and
oseltamivir or zanamivir for treatment of seasonal influenza A (H3N2), novel influenza A (H1N1), or influenza B virus infection.

The CDC now estimates that at least 1 million Americans have been infected with the novel H1N1 virus. The CDC estimate was derived from population–based surveys in areas that have reported incidences of influenza–like–illness to be 6 percent or higher. Five vaccine manufacturers are working to develop a vaccine for the novel H1N1 virus. CDC officials told ACIP members during the meeting that the agency is confident that vaccine – possibly as much as 60 million doses – will be available by October.

<< Previous
CDC Reinstates Hib Booster Dose for 12- to 15-month-olds

Next >>
Detecting and addressing adolescent issues and concerns:...

Update on 2009 pandemic influenza A (H1N1) virus
Cleveland Clinic Journal of Medicine, 10/05/09 Relevance Score: 85%

The first Pandemic of the 21st Century: A Review of the 2009 Pandemic Variant Influenza A (H1N1) Virus
Postgraduate Medicine, 10/02/09 Relevance Score: 84%

Comparison of a Rapid Antigen Test with Nucleic Acid Testing During Co-circulation of Pandemic Influenza A/H1N1 2009 and Seasonal Influenza A/H3N2
Journal of Clinical Microbiology, 11/13/09 Relevance Score: 83%

FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
Gen-Probe, 10/30/09 Relevance Score: 82%

Novartis completes shipment of US supply of Fluvirin seasonal influenza vaccine
Novartis, 10/07/09 Relevance Score: 82%